Treace Medical Concepts, Inc. reports results for the quarter ended June 30 - Earnings Summary

Treace Medical Concepts

07/08/2026 14:31

Treace Medical Concepts, Inc. TMCI.OQ reported a quarterly adjusted loss of 24 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of -28 cents.  The mean expectation of five analysts for the quarter was for a loss of 30 cents per share. Wall Street expected results to range from -30 cents to -29 cents per share.
Revenue fell 4.2% to $45.38 million from a year ago; analysts expected $44.02 million. 
Treace Medical Concepts, Inc.'s reported EPS for the quarter was a loss of 24 cents​.
The company reported a quarterly loss of $15.87 million.
Treace Medical Concepts, Inc. shares had risen by 10.1% this quarter and gained 78.8% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1.4% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "hold" and the breakdown of recommendations is 1 "strong buy" or "buy," 3 "hold" and 1 "sell" or "strong sell." The average consensus recommendation for the medical equipment, supplies & distribution peer group is  "buy."
Wall Street's median 12-month price target for Treace Medical Concepts, Inc. is $4.00, about 9.5% below its last closing price of $4.38
This summary was machine generated from LSEG data August 7 at 01:31 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
-0.30
-0.24
Beat
Mar. 31 2026 
-0.31
-0.28
Beat
Dec. 31 2025 
-0.15
-0.15
Met
Sep. 30 2025 
-0.28
-0.26
Beat